Skip header and navigation

5 records – page 1 of 1.

5-Aminosalicylate (5-ASA)

http://libcat.nshealth.ca/permalink/chpams35397
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1483
Available Online
View Pamphlet
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Colitis - drug therapy
Crohn Disease - drug therapy
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Colitis
Crohn's disease
Inflammatory bowel diseases
Abstract
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
Responsibility
Prepared by: Jennifer Stewart, RN; Gastroenterology
Prepared by: Kaleigh MacIsaac, B.ScPharm; Gastroenterology
Revised by: Alison Harding, B.Sc.
Revised by: Phyllis Durning, RN
Pamphlet Number
1483

Adalimumab (Humira®) therapy

http://libcat.nshealth.ca/permalink/chpams35127
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1207
Available Online
View Pamphlet
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1207

Corticosteriod therapy in inflammatory bowel disease

http://libcat.nshealth.ca/permalink/chpams35480
Capital Health (N.S.). Gastroenterology. Halifax, NS: Capital Health , 2014.
Pamphlet Number
1546
Available Online
View Pamphlet
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. What to expect after treatment, cost, precautions, side effects, and a list of symptoms that require you to contact your doctor are provided. ; This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Available Online
View Pamphlet
Corporate Author
Capital Health (N.S.). Gastroenterology
Alternate Title
Corticosteriod therapy in IBD
Place of Publication
Halifax, NS
Publisher
Capital Health
Date of Publication
2014
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Prednisone
Other Subjects
Inflammatory bowel diseases
Prednisone
Specialty
Gastroenterology
Medications
Abstract
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. What to expect after treatment, cost, precautions, side effects, and a list of symptoms that require you to contact your doctor are provided.
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Notes
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Responsibility
Prepared by: Gastroenterology
Pamphlet Number
1546

Golimumab (Simponi®) therapy

http://libcat.nshealth.ca/permalink/chpams35651
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1641
Available Online
View Pamphlet
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1641

Infliximab (Remicade) therapy

http://libcat.nshealth.ca/permalink/chpams34944
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1140
Available Online
View Pamphlet
Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Infliximab
Other Subjects
Inflammatory bowel diseases
Infliximab
Abstract
Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1140

Revise Search

Narrow By

   MORE